Artero Arturo, Esparcia Ana, Alberola Juan, Madrazo Manuel, Nogueira José M, Eiros José M
Department of Internal Medicine, Hospital Universitario Dr. Peset, Universitat de València, València, Spain.
Department of Microbiology, Hospital Universitario Dr. Peset, Universitat de València, València, Spain.
Int J Clin Pract. 2017 Sep;71(9). doi: 10.1111/ijcp.13001. Epub 2017 Sep 5.
Extended-spectrum beta-lactamase (ESBL)-producing Escherichia coli are currently common in community-onset infections, limiting therapeutic options. In this work we aim to identify the prevalence of and risk factors for ESBL-producing E. coli in elderly patients with urinary tract infections (UTI) admitted to hospital.
Prospective cohort study on elderly patients with E. coli UTI admitted to a university hospital in Spain, from January 2013 to December 2015. Clinical features, microbiology and outcomes were recorded from the electronic medical records and reviewed by two researchers. Cases were segregated according to ESBL-producing E. coli. Risk factors for ESBL-producing E. coli were analysed by multivariate analysis.
The prevalence of ESBL-producing E. coli was 27.4% (85/310). Healthcare-associated UTI was the only risk factor for ESBL-producing E. coli (OR 6.79; 95% CI 3.22-14.31, P < .001) by multivariate analysis. ESBL-producing E. coli was 43.9% in the healthcare-associated UTI group and 8.9% in the community-acquired UTI group (P < .001). Inadequate empirical antibiotic therapy and length of stay in hospital were higher in the ESBL-producing E. coli group than in the non-ESBL-producing E. coli group (62.3% vs 5.3% and 6.60 ± 3.69 days vs 5.61 ± 3.16 days, respectively). Mortality was not significantly different between groups (13% in ESBL-producing E. coli group vs 7.5% in non-ESBL-producing E. coli group, P = .140).
Healthcare-associated UTI was a risk factor for ESBL-producing E. coli in elderly patients with UTI admitted to hospital. Our results might help clinicians in choosing empirical antibiotics in an overall high rate setting of ESBL-producing E. coli.
产超广谱β-内酰胺酶(ESBL)的大肠杆菌目前在社区获得性感染中很常见,限制了治疗选择。在这项研究中,我们旨在确定住院的老年尿路感染(UTI)患者中产ESBL大肠杆菌的患病率及危险因素。
对2013年1月至2015年12月在西班牙一家大学医院住院的老年大肠杆菌UTI患者进行前瞻性队列研究。从电子病历中记录临床特征、微生物学及结局,并由两名研究人员进行审核。病例根据是否产ESBL大肠杆菌进行分类。通过多变量分析产ESBL大肠杆菌的危险因素。
产ESBL大肠杆菌的患病率为27.4%(85/310)。多变量分析显示,医疗保健相关UTI是产ESBL大肠杆菌的唯一危险因素(比值比6.79;95%置信区间3.22 - 14.31,P <.001)。在医疗保健相关UTI组中产ESBL大肠杆菌的比例为43.9%,在社区获得性UTI组中为8.9%(P <.001)。产ESBL大肠杆菌组的经验性抗生素治疗不当及住院时间长于非产ESBL大肠杆菌组(分别为62.3%对5.3%以及6.60±3.69天对5.61±3.16天)。两组间死亡率无显著差异(产ESBL大肠杆菌组为13%,非产ESBL大肠杆菌组为7.5%,P = 0.140)。
医疗保健相关UTI是住院老年UTI患者中产ESBL大肠杆菌的危险因素。我们的结果可能有助于临床医生在产ESBL大肠杆菌总体高发的情况下选择经验性抗生素。